Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Finance · ·
$25.07
▲ $0.45 (+1.8%)
Market data updated: 09/21 03:07 PM
Fundamentals updated: 09/21/2026
News analyzed: 09/21/2026
Market Cap
$464.70M
Day Range
$24.64 - $25.07
52-Week Range
$24.11 - $44.66
Beta
—
Next Earnings
27.10.2026
Support
$24.11
Resistance
$35.41
-44.9% (1Y)
Strengths: 3/23 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
MACD
MACD histogram is positive — rising momentum
Technical
Biggest negative driver
DCF Fair Value
Estimated fair value: $7.37 vs. price $25.07 (-70.6%)
Fair Value
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
43
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
Not enough data yet to generate this synthesis.
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
34
Quality
No data available
Value
43
Momentum
25
Risk
42
Sentiment
86
Fundamental
53
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Everyone's writing about AMERISAFE, Inc.. News trend score: 86. Reason: 9 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
32
🎯 Conviction (vs. Emotion)
38
Psychology
59
Fundamentals
53
Technical
25
Valuation
43
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
The price rise has far outpaced the actual improvement in fundamental data.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
-21%
Market Narrative
65
Fundamental Reality
38
Narrative Gap
+27
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
📈 3D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 97/100
🔴 Weakest match
Peter Lynch — 4/100
🗣️ Why do they disagree?
Based on his documented principles, the model estimates that investors focused on market cycles and disciplined risk‑reward setups—such as Nelson (93), Schwager (86) and Marks‑cycle (82)—see AMSF as favorably positioned and not overextended. In contrast, those applying stricter value or safety margins—Graham (52), Graham‑enterprising (36), Bagehot (50) and Fisher (17)—assign lower scores, reflecting concerns about valuation, lack of a clear quality growth story, or insufficient balance‑sheet data. Mid‑range assessments from Marks (43), Loeb (44) and the efficient‑market view (33) highlight mixed expectations and moderate risk to capital. The divergence therefore arises from each methodology’s weighting of cycle timing, risk‑reward, intrinsic value and growth quality, leading to both optimistic and cautious conclusions.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 97
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 96
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 79
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 66
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 57
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 51
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 50
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 50
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 46
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 38
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 36
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 35
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🔴 32
Weak case — Malkiel/Bogle would say a low-cost index is the simpler bet
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 24
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 17
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 4
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 40%
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (2 bullish · 8 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Low confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
14.9%
EBITDA Margin
—
ROE
18.7%
ROA
4.2%
ROIC
—
EPS
$2.48
Cash
$61.93M
Total Debt
—
Current Ratio
—
Debt/Equity
—
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 11.9.2026 | $0.410 |
| 12.6.2026 | $0.410 |
| 11.6.2026 | $0.410 |
| 13.3.2026 | $0.410 |
| 12.3.2026 | $0.410 |
| 5.12.2025 | $1.390 |
| 4.12.2025 | $1.390 |
| 12.9.2025 | $0.390 |
| 11.9.2025 | $0.390 |
| 13.6.2025 | $0.390 |
| 12.6.2025 | $0.390 |
| 7.3.2025 | $0.390 |
How is Fair Value calculated? →
Current Price
$25.07
Estimated Fair Value (DCF)
$7.37
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-70.6%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
2.5%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 2.5% | $9.14M | $8.39M |
| 2 | 2.5% | $9.37M | $7.89M |
| 3 | 2.5% | $9.61M | $7.42M |
| 4 | 2.5% | $9.85M | $6.98M |
| 5 | 2.5% | $10.09M | $6.56M |
Base FCF (last actual year)
$8.92M
Terminal Value
$159.16M
Present Value of Terminal Value
$103.44M
Enterprise Value
$140.67M
Net Debt
$0
Equity Value
$140.67M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$13.18
Tangible Book Value per Share (Tangible NAV)
$13.18
Sentiment based on basic keywords (not AI) — 9 positive, 8 neutral, 3 negative out of the last 20 articles.
SeekingAlpha · 18.9.2026
Yahoo · 18.9.2026
Yahoo · 10.9.2026
Business Wire · 10.9.2026
Yahoo · 4.9.2026
PR Newswire · 4.9.2026
SeekingAlpha · 4.9.2026
Healthcare Dive · 31.8.2026
Zacks · 20.8.2026
SeekingAlpha · 17.8.2026
Zacks · 17.8.2026
SeekingAlpha · 7.8.2026
Benzinga · 23.7.2026
GuruFocus.com · 22.7.2026
MarketBeat · 22.7.2026
Zacks · 22.7.2026
Moby · 22.7.2026
SeekingAlpha · 22.7.2026
Benzinga · 22.7.2026
Zacks · 21.7.2026
AMERISAFE, Inc. (AMSF) currently has a StockIQ AI score of 43/100, rated "Weak" (a partial score — based on only 6 of 7 categories, some data is currently unavailable). The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
AMSF currently scores 43/100 (Weak) across the categories we measure (a partial score — based on only 6 of 7 categories, some data is currently unavailable). StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, AMSF's estimated fair value is $7.37, which is 70.6% below the current price of $25.07. This is one valuation model among several signals in the fair-value category, not a price target.
AMSF's technical score is 25/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: MACD histogram is positive — rising momentum; P/E: 10.0; CMF 20 days: 0.15.
Based on the real signals StockIQ computed: Estimated fair value: $7.37 vs. price $25.07 (-70.6%); Calmar: -0.37 (3y annualized return -21.8% / max drawdown 58.7%); Earnings per share (EPS) growth: -14.5%.
Yes — AMSF has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Wise Raymond F. Jr. | Exercise of Derivative Securities | 1.8.2026 | 4,257 | +4,257 | — |
| Wise Raymond F. Jr. | Tax Withholding in Shares | 1.8.2026 | 1,846 | -1,846 | $29.04 |
| Wise Raymond F. Jr. | Exercise of Derivative Securities | 1.8.2026 | 4,257 | -4,257 | — |
| Wise Raymond F. Jr. | Exercise of Derivative Securities | 1.8.2026 | 10,818 | +4,257 | — |
| Wise Raymond F. Jr. | Tax Withholding in Shares | 1.8.2026 | 8,972 | -1,846 | $29.04 |
| Wise Raymond F. Jr. | Exercise of Derivative Securities | 1.8.2026 | 9,878 | -4,257 | — |
| BROWN MICHAEL J | Grant/Award from Employer | 10.6.2026 | 2,340 | +2,340 | — |
| MORRIS JARED A | Grant/Award from Employer | 10.6.2026 | 2,340 | +2,340 | — |
| Roach Randy | Grant/Award from Employer | 10.6.2026 | 2,340 | +2,340 | — |
| TRAYNOR SEAN | Grant/Award from Employer | 10.6.2026 | 2,340 | +2,340 | — |
| Greer Billy B | Grant/Award from Employer | 10.6.2026 | 2,340 | +2,340 | — |
| Fontenot Teri G. | Grant/Award from Employer | 10.6.2026 | 2,340 | +2,340 | — |
| GARCIA PHILIP A | Grant/Award from Employer | 10.6.2026 | 2,340 | +2,340 | — |
| Fontenot Teri G. | Grant/Award from Employer | 10.6.2026 | 14,008 | +2,340 | — |
| BROWN MICHAEL J | Grant/Award from Employer | 10.6.2026 | 15,761 | +2,340 | — |
| Roach Randy | Grant/Award from Employer | 10.6.2026 | 18,862 | +2,340 | — |
| Greer Billy B | Grant/Award from Employer | 10.6.2026 | 8,861 | +2,340 | — |
| MORRIS JARED A | Grant/Award from Employer | 10.6.2026 | 25,075 | +2,340 | — |
| GARCIA PHILIP A | Grant/Award from Employer | 10.6.2026 | 27,243 | +2,340 | — |
| TRAYNOR SEAN | Grant/Award from Employer | 10.6.2026 | 18,326 | +2,340 | — |
| Ramos Guillermo A | Grant/Award from Employer | 7.5.2026 | 33,003 | +33,003 | — |
| Ramos Guillermo A | Grant/Award from Employer | 7.5.2026 | 2,970 | +2,970 | — |
| Ramos Guillermo A | Grant/Award from Employer | 7.5.2026 | 33,003 | +33,003 | — |
| Ramos Guillermo A | Grant/Award from Employer | 7.5.2026 | 35,973 | +2,970 | — |
| Lestage Henry O IV | Grant/Award from Employer | 27.4.2026 | 22,121 | +22,121 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
909,626 shares short as of 2026-08-31 · vs. 806,624 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
60.6% of trading volume this week was short selling, vs. 50.0% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology